Facioscapulohumeral Muscular Dystrophy clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Sorry, accepting new patients by invitation only
This study is an open-label extension to evaluate the safety and tolerability of long-term dosing of Losmapimod in patients with FSHD1 who participated in the ReDux4 study.
Irvine, California and other locations